References
- Varga J, Toth B, Kocsube S, et al. Evolutionary relationships among Aspergillus terreus isolates and their relatives. Antonie Van Leeuwenhoek 2005; 88: 141–150
- Symoens F, Bouchara JP, Heinemann S, Nolard N. Molecular typing of Aspergillus terreus isolates by random amplification of polymorphic DNA. J Hosp Infect 2000; 44: 273–280
- Baddley JW, Pappas PG, Smith AC, Moser SA. Epidemiology of Aspergillus terreus at a university hospital. J Clin Microbiol 2003; 41: 5525–5529
- Gandra RF, Simao RC, Matsumoto FE, et al. Genotyping by RAPD-PCR analyses of Malassezia furfur strains from pityriasis versicolor and seborrhoeic dermatitis patients. Mycopathologia 2006; 162: 273–280
- Steinbach, WJ, Benjamin, DK, Jr,Kontoyiannis, DP, , et al. Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases. Clin Infect Dis 2004; 39: 192–198.
- Raper BK, Fennell DI. The Genus Aspergillus. Williams and Wilkins Co, Baltimore 1965
- Liu K, Howell DN, Perfect JR, Schell WA. Morphologic criteria for the preliminary identification of Fusarium, Paecilomyces, and Acremonium species by histopathology. Am J Clin Pathol 1998; 109: 45–54
- Lass-Florl C, Rief A, Leitner S, et al. In vitro activities of amphotericin B and voriconazole against aleurioconidia from Aspergillus terreus. Antimicrob Agents Chemother 2005; 49: 2539–2540
- Balajee SA, Gribskov JL, Hanley E, Nickle D, Marr KA. Aspergillus lentulus sp nov., a new sibling species of A., fumigatus. Eukaryotic Cell 2005; 4: 625–632
- Hong SB, Shin HD, Hong J, et al. New taxa of Neosartorya and Aspergillus in Aspergillus section Fumigati. Antonie Van Leeuwenhoek 2008; 93: 87–98
- Espinel-Ingroff A. In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi. J Clin Microbiol 2001; 39: 954–958
- Espinel-Ingroff A. Germinated and nongerminated conidial suspensions for testing of susceptibilities of Aspergillus spp. to amphotericin B, itraconazole, posaconazole, ravuconazole, and voriconazole. Antimicrob Agents Chemother 2001; 45: 605–607
- Sutton DA, Sanche SE, Revankar SG, Fothergill AW, Rinaldi MG. In vitro amphotericin B resistance in clinical isolates of Aspergillus terreus, with a head-to-head comparison to voriconazole. J Clin Microbiol 1999; 37: 2343–2345
- Meletiadis J, Antachopoulos C, Stergiopoulou T, et al. Differential fungicidal activities of amphotericin B and voriconazole against Aspergillus species determined by microbroth methodology. Antimicrob Agents Chemother 2007; 51: 3329–3337
- Walsh TJ, Petraitis V, Petraitiene R, et al. Experimental pulmonary aspergillosis due to Aspergillus terreus: pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B. J Infect Dis 2003; 188: 305–319
- Caston JJ, Linares MJ, Gallego C, et al. Risk factors for pulmonary Aspergillus terreus infection in patients with positive culture for filamentous fungi. Chest 2007; 131: 230–236
- Morgan J, Wannemuehler KA, Marr KA, et al. Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program. Med Mycol 2005; 43(Suppl. 1)S49–S58
- Mellado E, Alcazar-Fuoli L, Garcia-Effron G, et al. New resistance mechanisms to azole drugs in Aspergillus fumigatus and emergence of antifungal drugs-resistant A. fumigatus atypical strains. Med Mycol 2006; 44(Suppl. 1)S367–S371
- Yaguchi T, Horie Y, Tanaka R, et al. Molecular phylogenetics of multiple genes on Aspergillus section Fumigati isolated from clinical specimens in Japan. Nippon Ishinkin Gakkai Zasshi 2007; 48: 37–46
- Perfect JR, Cox GM, Lee JY, et al. The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis. Clin Infect Dis 2001; 33: 1824–1833
- Balajee SA, Houbraken J., Verweij PE, et al. Aspergillus species identification in the clinical setting. Studies in Mycology 2007; 59: 39–46
- Healy M, Reece K, Walton D, et al. Identification to the species level and differentiation between strains of Aspergillus clinical isolates by automated repetitive-sequence-based PCR. J Clin Microbiol 2004; 42: 4016–4024
- Lass-Florl C, Grif K, Kontoyiannis DP. Molecular typing of Aspergillus terreus isolates collected in Houston, Texas, and Innsbruck, Austria: evidence of great genetic diversity. J Clin Microbiol 2007; 45: 2686–2690
- Cloud, J, Bauman, S, Neary, B, Ludwig, K, Ashwood, E. Abstr. C-345. In: 106th General Meeting of the American Society of Microbiologists; 2006.
- Lass-Florl C, Rath P, Niederwieser D, et al. Aspergillus terreus infections in haematological malignancies: molecular epidemiology suggests association with in-hospital plants. J Hosp Infect 2000; 46: 31–35
- Anaissie EJ, Costa SF. Nosocomial aspergillosis is waterborne. Clin Infect Dis 2001; 33: 1546–1548
- Vesper S, McKinstry C, Hartmann C, et al. Quantifying fungal viability in air and water samples using quantitative PCR after treatment with propidium monoazide (PMA). J Microbiol Methods 2008; 72: 180–184